Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands ...

BIB ETF is best suited for high-risk, active investors in the accumulation phase or retirees managing portfolios hands-on.

Bio shares rose sharply after announcing upcoming presentations on its obesity treatment candidate at two industry ...

Biotech stocks rebound after years of weakness as M&A, lower rates and easing policy fears draw investors back to the sector.

Replimune stock doubled to $9.00 after FDA accepted its resubmitted application for melanoma drug RP1, with decision expected ...

The investment seeks daily investment results, before fees and expenses, of 200% of the daily performance of the NYSE Biotechnology Index. The fund, under normal circumstances, invests at least 80% of ...

BioNTech (BNTX) shares have been on a bit of a ride recently, with the latest movement sparking conversations among those watching the biotech space. Investors are weighing the stock’s performance ...

Rani Therapeutics Holdings ($RANI), a clinical-stage penny biotech stock, soared nearly 250% on Friday and continued to trade ...

Purple Biotech Ltd. ('Purple Biotech” or 'the Company”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance ...

Adaptive Biotechnologies (ADPT) is a commercial-stage biotech with strong technical momentum. ・Shares are up 250% in the past ...

ETHZilla's 1-for-10 reverse stock split took effect October 20, 2025, raising shares to $16.80 to attract institutional ...

Investing.com -- Applied DNA Sciences Inc (NASDAQ:BNBX) stock surged 50% in premarket trading Wednesday after the biotechnology company announced the successful closing of a private investment in ...